HIGH

Curosurf 240 mg Poractant Alfa Recalled for Sterility Concerns (2026)

Chiesi USA recalled 7,235 Curosurf vials distributed nationwide to hospitals and clinics. The recall cites a lack of assurance of sterility. Healthcare providers should stop using the product immediately and contact Chiesi USA for guidance.

Quick Facts at a Glance

Recall Date
March 17, 2026
Hazard Level
HIGH
Brands
CUROSURF, Chiesi USA, Inc.
Category
Health & Personal Care
Sold At
Multiple Retailers
Geographic Scope
1 states
At-Risk Groups
INFANTS, GENERAL

Hazard Information

Lack of Assurance of Sterility

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Chiesi USA, Inc. or your healthcare provider for guidance. Notification method: Letter

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

About This Product

Curosurf is a neonatal surfactant used to treat respiratory distress in preterm infants. It is delivered intratracheally in a hospital setting.

Why This Is Dangerous

Lack of sterility could introduce microbial contamination, potentially causing infection in vulnerable neonates.

Industry Context

This recall is not indicated as part of a broader industry pattern at this time.

Real-World Impact

Hospitals must halt use of affected vials and coordinate with distributors for replacement; potential patient risk if contaminated product is administered.

Practical Guidance

How to identify if yours is affected

  1. Verify NDC 10122-510-03 on the product label.
  2. Check lot numbers 1213748, 1215076, 1215077.
  3. Confirm expiration dates 09/2026 or 10/2026.

Where to find product info

NDC and lot numbers are printed on vial labels and packaging.

What timeline to expect

Replacements or credits are typically coordinated within hospital supply chains over several weeks; patient care adjustments may occur during this时间.

If the manufacturer is unresponsive

  • Escalate to hospital procurement leadership
  • Contact Chiesi USA’s recall notice for escalation procedures
  • File a report with the hospital's CPS/CQA department

How to prevent similar issues

  • Source neonatal surfactants only through approved hospital distributors
  • Verify sterility and batch information before administration
  • Maintain updated recall contact lists for suppliers

Documentation advice

Keep a copy of the recall notice, purchase records, lot numbers, and all correspondences with the supplier.

Product Details

Product: Curosurf (poractant alfa) Intratracheal Suspension, 240 mg, 3L Single-Dose Vial, Rx only. NDC: 10122-510-03. Distributed nationwide to healthcare facilities. Quantity recalled: 7,235 vials. Lot numbers: 1213748, 1215076, 1215077. Expiration dates observed: 09/2026 and 10/2026. Sold by: Nationwide healthcare distribution. Manufacturer: Chiesi USA, Inc., Cary, NC.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 7,235 vials recalled
  • NDC 10122-510-03
  • Lot numbers 1213748, 1215076, 1215077
  • Exp. dates 09/2026 and 10/2026
  • Rx-only product
  • Distributed nationwide

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
INFANTSGENERAL
Injury Types
POISONINGOTHER

Product Classification

Product TypeCurosurf (poractant alfa) Intratracheal Suspension 240 mg, 3L Single-Dose Vial
Sold At
Multiple Retailers

Product Details

Model Numbers
Lot #: 1213748
Exp. Date 09/2026
1215076
1215077
Exp. Date 10/26.
UPC Codes
10122-510
10122-510-03
10122-510-01
Affected States
ALL
Report Date
April 1, 2026
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Vehicles & Parts
HIGH

Mazda CX-70 Recall 2025 for Powertrain Control Module Software May Lose Drive Power

Mazda North American Operations is recalling 2024 CX-90 and 2025 CX-70 SUVs sold through Mazda dealers. The PCM and ECM software can illuminate malfunction indicator lights and cause a loss of drive power, increasing crash risk. Owner notification letters were mailed December 19, 2024, and Mazda will reprogram the PCM and ECM at no charge.

Mazda
Loss of
Read more
Vehicles & Parts
HIGH

Nissan Kicks 2025 Certification Label Recall for GVWR/GAWR Errors (PD136, PMA47)

Nissan North America is recalling certain 2025 Nissan Kicks vehicles sold through Nissan dealers nationwide. The certification label may print incorrect GVWR and GAWR values, risking overload. Some SR trims with a 19-inch wheel package may display an incorrect wheel size on the label, and owners should contact their Nissan dealer to arrange replacement labels.

Nissan
An overloaded
Read more